Anhui DeepBlue Medical Technology Co.,Ltd. Company News

Company News Nov 06, 2026

Invitation: Visit DEEPBLUE Medical at MEDICA 2026 in Düisseldorf

Invitation: Visit DeepBlue Medical at MEDICA 2026 in Düisseldorf Booth No.: 1G39-1 Date: November 16-19,2026| Venue: Messe Düisseldorf, Germany Dear Valued Partners and Customers, Anhui Deepblue Medical Technology Co. td. sincerely invites you to visit our booth at MEDIcA 2026, the world's leading medical technology trade fair held in Düsseldorf, Germany. About DeepBlue Medical Founded in 2010 and based in Anhui Province, DeepBlue Medical is a leading high-tech lVD manufacturer with over 16 years of specialization in the R&D, production and sales of rapid in-vitro diagnostic reagents. We have always been committed to technological innovation and strict quality control, and have obtained MDsAP and ls0 13485 quality management system certifications, as well as CE0123 and CE3018 certificates for home-use self-test products. Our products have been registered and widely recognized in Germany, ltaly, Portugal, Mexico, Brazi, Peru, indonesia,Bangladesh, the United Arab Emirates, lanzania, Turkey, the United Kingdom, the United States and many other countries and regions. With strong R&D capabilities, highly automated production lines, large production capacity and responsive service, we help global partners control product quality while optimizing costs, and pursue long term win-win cooperation. Our professional team will be on site to introduce product details, discuss OEM/ODM customization, distribution cooperation and local registration support. We welcome you to schedule a dedicated meeting with us in advance. We look forward to meeting you in Düsseldorf, exploring cooperation opportunities and working together to advance global healthcare. Best regards, Anhui Deepblue Medical Technology Co., Ltd.

Company News Oct 23, 2026

Meet DeepBlue Medical at the 140th China Import and Export Fair (Canton Fair)

DeepBlue Medical is pleased to announce our participation in the 140th China Import and Export Fair (Canton Fair), held from October 31 to November 4, 2026, at the Pazhou International Exhibition Center, Guangzhou, China. We sincerely invite global partners, customers, and industry colleagues to visit our booth and explore our latest advancements in point-of-care testing (POCT) and home-use self-test solutions. Booth Information Booth No.: 9.2 I 11–12 Date: October 31 – November 4, 2026 Venue: Pazhou International Exhibition Center Address: 380 Yuejiangzhong Road, Haizhu District, Guangzhou, China At the fair, DeepBlue Medical will showcase a comprehensive range of innovative POCT products and home-use self-testing devices designed for fast, accurate, and convenient clinical and consumer testing. Our team will be available on-site to discuss product details, customization opportunities, distribution cooperation, and long-term partnership models. We look forward to welcoming you at Booth 9.2 I 11–12 and building successful cooperation together.

Company News Oct 16, 2026

Anhui Deepblue Medical Welcomes You at CMEF 2026

Oct 21, 2026 We are pleased to announce that Anhui Deepblue Medical Technology Co., Ltd. will be exhibiting at the 94th China International Medical Equipment Fair (CMEF, Autumn), one of the world’s largest and most influential medical equipment expos. Event Details: Date: Oct 21–24, 2026 Venue: Beijing Capital International Exhibition & Convention Center, Beijing, China Booth: Hall A2, Booth A2A10 Join us to explore our latest home self-testing in vitro diagnostic products at this leading medical industry platform. As a national high-tech enterprise, we look forward to connecting with distributors, hospital procurement professionals and global industry partners. For inquiries or to schedule a meeting, please contact us in advance. See you in Beijing!

Company News Aug 05, 2026

Anhui Elvys Biotech, Subsidiary of Deep‑Blue Medical, Earns NSF GMP Certification for Dietary Supplement Manufacturing

Anhui Elvys Biotech Co., Ltd., a subsidiary of Anhui DEEPBLUE Medical, has officially obtained the Certificate of Conformity issued by NSF International, marking our full compliance with strict United‑States‑based good‑manufacturing‑practice standards for dietary‑supplement production. The facility located in Hefei High‑tech Zone passed the audit against the latest NSF/ANSI 455‑2‑2024 standard. The certification covers full‑scale manufacturing workflows including formulation, encapsulation, tableting, soft‑gel processing, gummy production, mixing, packaging, quality inspection and warehouse management. Our certified product scope includes capsules, gummies, powders, soft gels and tablets. Valid from July 24, 2026 until September 21, 2027, this NSF accreditation demonstrates that our production plant meets FDA‑recognized 21‑CFR regulatory requirements. It serves as an authoritative international passport for Elvys Biotech to supply premium‑grade health‑care products to the United‑States market and global clients. DEEPBLUE Medical will keep upgrading our quality‑control system and deliver reliable, compliant nutritional‑supplement solutions for worldwide partners.

Company News Jul 21, 2026

Anhui Deepblue Medical Welcomes You at MEDITECH 2026

We are pleased to announce that Anhui Deepblue Medical Technology Co., Ltd. will be exhibiting at MEDITECH 2026, the premier international health fair in Latin America, co-organized by Messe Düsseldorf North America (the organizer of MEDICA) and CORFERIAS . Event Details: Date: July 28–31, 2026 Venue: CORFERIAS – Bogotá International Business and Exhibition Center, Bogotá, Colombia Booth: 413C Join us to explore our latest in vitro diagnostic reagents and medical devices at this key gateway to the Andean and Latin American markets . As a national high‑tech enterprise, we look forward to connecting with regional distributors, hospital procurement professionals, and industry partners. For inquiries or to schedule a meeting, please contact us in advance. See you in Bogotá!

Company News Jul 21, 2026

Anhui Deepblue Medical Welcomes You at ADLM 2026

We are pleased to announce that Anhui Deepblue Medical Technology Co., Ltd. will be exhibiting at ADLM 2026 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), the world‘s premier event for clinical laboratory medicine and in vitro diagnostics. Event Details: Date: July 26–30, 2026 Venue: Anaheim Convention Center, Anaheim, CA, USA Booth: 3386 Join us to explore our latest innovations in in vitro diagnostic reagents and medical devices. As a national high‑tech enterprise, we look forward to connecting with global leaders, partners, and customers at North America’s largest IVD exhibition. For inquiries or to schedule a meeting, please contact us in advance. See you in Anaheim!

Company News Jun 26, 2026

Welcomes You at WHX Labs Bangkok 2026

Anhui Deepblue Medical Welcomes You at WHX Labs Bangkok 2026 We are pleased to announce that Anhui Deepblue Medical Technology Co., Ltd. will be exhibiting at WHX Labs Bangkok 2026, Southeast Asia‘s leading healthcare and medical laboratory event. Event Details: Date: July 8–10, 2026 Venue: Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand Booth: G10 Join us to explore our latest innovations in in vitro diagnostic reagents and medical devices. Our team looks forward to connecting with partners and customers from across the region. For inquiries or to schedule a meeting, please contact us in advance. See you in Bangkok!

Company News May 22, 2026

Anhui Deepblue Medical Receives EU IVDR Certificate for Self-Testing Products

Anhui Deepblue Medical Receives EU IVDR Certificate for Self-Testing Products HEFEI, China – May 22, 2026 – Anhui Deepblue Medical Technology Co., Ltd. has obtained the EU Technical Documentation Assessment Certificate under Regulation (EU) 2017/746 (IVDR). The certified products include: SARS‑CoV‑2 & Influenza A+B & RSV & ADV Antigen Combo Test Kit (Colloidal Gold) Influenza A+B & COVID‑19 (SARS‑CoV‑2) Antigen Test Kit (Colloidal Gold) These tests are intended for non‑prescription home use with self‑collected nasal swab samples. This certificate confirms that Deepblue Medical has met the technical documentation requirements of Annex IX, Chapter II of IVDR, a key step toward placing its self-testing rapid diagnostic products on the European market. -------About Anhui Deepblue Medical A national high‑tech enterprise focusing on R&D, production and sales of in vitro diagnostic reagents and medical devices.

Company News May 14, 2026

Invitation – HOSPITALAR 2026, São Paulo, Brazil

Dear Valued Customer / Partner, The 4‑day International Medical Equipment Exhibition HOSPITALAR 2026 will soon be held in São Paulo, Brazil. Jointly organized with the renowned German MEDICA exhibition and certified by the International Hospital Federation (IHF), HOSPITALAR has been awarded the title of “Trustworthy Commercial Exhibition” by the U.S. Department of Commerce and remains the most authoritative medical device and supplies exhibition in Brazil and the entire Latin American region. As a national high‑tech enterprise, Anhui DEEPBLUE Medical Technology Co., Ltd. (hereinafter referred to as “DEEPBLUE Medical”) focuses on the R&D, production and sales of in vitro diagnostic reagents, medical devices and medical health products. This will be the fourth time for DEEPBLUE Medical to appear at this exhibition, and the fruitful results of the past three participations have strengthened the company’s determination to continue to deepen the Latin American market. At HOSPITALAR 2026, DEEPBLUE Medical will stunningly launch a series of products backed by more than ten years of R&D accumulation, covering infectious disease detection, pet detection, drug detection, maternal and gynecological detection, female fertility detection and other series, which we believe will attract many purchasers to stop by. To enhance the attractiveness of our products, DEEPBLUE Medical will once again set up a product experience area at the booth, allowing customers to personally participate in disease detection experiences and intuitively feel the product advantages. We cordially invite you to visit our booth and explore how our innovative solutions can support your business in the Latin American market. Our professional team will be on site to conduct live demonstrations and discuss potential cooperation. Exhibition details: Exhibition name: HOSPITALAR 2026 Date: May 19 – 22, 2026 Venue: São Paulo Expo, São Paulo, Brazil Booth number: C-126 Company name: Anhui DEEPBLUE Medical Technology Co., Ltd. Through this exhibition, DEEPBLUE Medical aims to further expand its brand awareness in the Latin American region and establish in‑depth connections with trade professionals from Brazil and neighboring countries, laying a solid foundation for follow‑up cooperation. In the future, DEEPBLUE Medical will continue to innovate and contribute more to the global medical and health cause through international exhibition platforms. We look forward to welcoming you at HOSPITALAR 2026! Sincerely, The DEEPBLUE Medical Team

Company News Sep 04, 2025

Deepblue Medical Earns EU IVDR Certification

DEEPBLUE Medical Achieves IVDR Certification for Early Pregnancy and Ovulation Tests, Along with EU Quality Management System Certificate Anhui DEEPBLUE Medical Technology Co., Ltd. is proud to announce a significant milestone in our commitment to global quality standards and compliance. The company has successfully obtained EU IVDR Technical Documentation Assessment Certificates for its Early Pregnancy Test and Ovulation Test, as well as the EU Quality Management System Certificate issued by TÜV SÜD Product Service GmbH. The certifications were granted under Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices (IVDR), covering both Annex IX Chapter I (Quality Management System) and Annex IX Chapter II (Technical Documentation Assessment). These approvals confirm that DEEPBLUE Medical’s products meet the rigorous requirements of the European market, ensuring the highest standards of safety, performance, and reliability. <<< EU Quality Management System Certificate (Valid: 2025–2030) <<< IVDR Certificate for Early Pregnancy Test (Valid: 2025–2030) <<< IVDR Certificate for Ovulation Test (Valid: 2025–2030) Achieving these certificates represents a major step forward in DEEPBLUE Medical’s global strategy, strengthening our ability to expand within the European Union and other international markets. It demonstrates not only our dedication to product innovation and regulatory compliance, but also our mission to provide trusted, high-quality diagnostic solutions worldwide. DEEPBLUE Medical will continue to uphold the principles of innovation, quality, and responsibility, contributing to the advancement of global healthcare with reliable diagnostic products.

Company News Jul 10, 2025

Statement of COVID-19 Variants

Statement of COVID-19 Variants For full details, please refer to the attached document below. --- Statement of COVID-19 Variants

Company News Jul 02, 2025

DEEPBLUE Medical Receives Malaysian Registration for Dengue NS1 & IgG/IgM Combo Test Kit

Hefei, China – July 2025 — Anhui DEEPBLUE Medical Technology Co., Ltd. is pleased to announce that its Dengue NS1 & IgG/IgM Combo Test Kit (Colloidal Gold) has officially received the Medical Device Registration Certificate from the Medical Device Authority (MDA) of Malaysia, under the Medical Device Act 2012 (Act 737), Section 5(1). This certification confirms that the Dengue Combo Test Kit complies with Malaysian regulatory requirements and is officially approved for distribution and use in the Malaysian market. The test kit enables rapid and simultaneous detection of Dengue NS1 antigen and IgG/IgM antibodies, providing critical early diagnostic support for clinicians in managing dengue fever outbreaks. The recognition by Malaysia's regulatory authority highlights DEEPBLUE Medical’s commitment to high-quality diagnostics and international regulatory compliance, further expanding its presence in Southeast Asia. ------------------------------------------------------------------------ About Dengue Virus Dengue virus is a mosquito-borne virus primarily transmitted by Aedes aegypti mosquitoes. It belongs to the Flavivirus genus and has four distinct serotypes (DENV-1 to DENV-4). Dengue is commonly found in tropical and subtropical regions, with high prevalence in Southeast Asia, South Asia, Latin America, Africa, and parts of the Pacific Islands. Symptoms of Dengue typically appear 4–10 days after infection and may include: 1.High fever 2.Severe headache 3.Joint and muscle pain (often called "breakbone fever") 4.Skin rash 5.Nausea and vomiting 6.In severe cases, it can lead to Dengue Hemorrhagic Fever or Dengue Shock Syndrome, which can be life-threatening. Early detection and supportive care are key to effective management and prevention of complications.